Tenofovir Monotherapy versus Tenofovir plus Lamivudine or Telbivudine Combination Therapy in Treatment of Lamivudine-Resistant Chronic Hepatitis B

Tenofovir disoproxil fumarate (TDF) monotherapy is a therapeutic option for chronic hepatitis B (CHB) patients infected with hepatitis B virus (HBV) variants resistant to lamivudine (LAM). We evaluated the antiviral efficacy and safety of TDF alone compared to those of TDF plus LAM or telbivudine (L...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Lee, Yun Bin, Jung, Eun Uk, Kim, Bo Hyun, Lee, Jeong-Hoon, Cho, Hyeki, Ahn, Hongkeun, Choi, Won-Mook, Cho, Young Youn, Lee, Minjong, Yoo, Jeong-Ju, Cho, Yuri, Lee, Dong Hyeon, Cho, Eun Ju, Yu, Su Jong, Park, Sung Jae, Kim, Yoon Jun, Park, Joong-Won, Lee, Youn Jae, Kim, Chang-Min, Yoon, Jung-Hwan, Kim, Chung Yong, Lee, Hyo-Suk
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2015
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335865/
https://ncbi.nlm.nih.gov/pubmed/25421484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04454-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi